1 – 10 of 183
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Serum immuno-oncology markers carry independent prognostic information in patients with newly diagnosed metastatic breast cancer, from a prospective observational study
(
- Contribution to journal › Article
-
Mark
A prospective cohort study identifying radiologic and tumor related factors of importance for breast conserving surgery after neoadjuvant chemotherapy
2023) In European Journal of Surgical Oncology(
- Contribution to journal › Article
- 2022
-
Mark
The Prognostic Role of Intratumoral Stromal Content in Lobular Breast Cancer
(
- Contribution to journal › Article
-
Mark
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
(
- Contribution to journal › Article
-
Mark
How Reliable Are Gene Expression-Based and Immunohistochemical Biomarkers Assessed on a Core-Needle Biopsy? A Study of Paired Core-Needle Biopsies and Surgical Specimens in Early Breast Cancer
(
- Contribution to journal › Article
-
Mark
The NILS Study Protocol : A Retrospective Validation Study of an Artificial Neural Network Based Preoperative Decision-Making Tool for Noninvasive Lymph Node Staging in Women with Primary Breast Cancer (ISRCTN14341750)
(
- Contribution to journal › Article
-
Mark
Prediction of node negative breast cancer and high disease burden through image analysis software on mammographic images and clinicopathological data
2022)(
- Contribution to conference › Abstract
-
Mark
Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial
(
- Contribution to journal › Article
-
Mark
The implementation of a noninvasive lymph node staging (NILS) preoperative prediction model is cost effective in primary breast cancer
(
- Contribution to journal › Article
-
Mark
Autoimmunity to selenoprotein P predicts breast cancer recurrence
(
- Contribution to journal › Article